1.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
2.
Expression and Regulation of Urokinase-type Plasminogen Activator in Supraglottic Laryngeal Cancer;
尿激酶型纤溶酶原激活剂在声门上型喉癌中的表达及调节机制
3.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
4.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响
5.
Treatment of Experimental Hepatic Fibrosis by Combination of Urokinase-type Plasminogen Activator and Hepatocyte Growth Factor Gene Delivery;
尿激酶型纤溶酶原激活剂和肝细胞生长因子联合基因治疗实验性肝纤维化
6.
Effect of Chinese Hebal Compound of Different Treating Principles on uPA of Cholestasis-induced Liver Fibrosis Rat
不同治则中药复方对胆汁淤积性肝纤维化大鼠尿激酶型纤溶酶原激活剂的影响
7.
Dynamic changes and its significance of urokinase-plasminogen activator during forming progress of cholestatic liver fibrosis in rats
尿激酶型纤溶酶原激活剂在大鼠胆汁淤积性肝纤维化形成过程中的动态变化及其意义
8.
Expression and Prognostic Significance of Nuclear Factor-kappaBp-65 and uPA in Cervical Carcinoma;
核转录因子-kBp65和尿激酶型纤溶酶原激活剂在人宫颈癌中的表达及预后意义
9.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
10.
Comparative study on intravenous rt-PA and uroninase thrombolytic strategy for acute myocardial infarction
重组组织型纤溶酶原激活剂与尿激酶静脉内溶栓治疗急性心肌梗死的比较研究
11.
Effects of Tang Maiping on Plasminogen Activeator Inhibior in Blood Vessel of Type 2 Diabetic Rats
糖脉平对2型糖尿病大鼠血管纤溶酶原激活抑制剂表达的影响
12.
Cloning and Expression of Urokinase Type Plasminogen Activator cDNA
尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
13.
The Effect of Amiloride-an Inhibitor of Urokinase on the Pathology of Rat COPD Model;
尿激酶型纤溶酶原激活物抑制剂—氨氯吡咪对大鼠COPD模型病理改变的影响
14.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
15.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
16.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
17.
Study on the Transcriptional Regulation of Urokinase Plasminogen Activator in Human Lung Cancer;
尿激酶型纤溶酶原激活物在人肺癌细胞中表达调控的研究
18.
The Experiment Research That the uPA to Suffer from the Relativity with the Arthritis Disease;
尿激酶型纤溶酶原激活物（uPA）与关节炎性疾患相关性的实验研究